Position history for Mirae Asset Global Investments Co., Ltd.'s holdings in ARROWHEAD PHARMACEUTICALS IN
Mirae Asset Global Investments Co., Ltd. holds 7,304 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $457,961 as of 2026-Q1. The position was increased (+10.7% shares). ARWR represents 0.0% of Mirae Asset Global Investments Co., Ltd.'s portfolio.
Current Value
$457,961
Current Shares
7,304
Total Value Change
+$362,702
Total Shares Change
+3,596
Other major holders of ARWR: BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC
Increased |
| 7,304 |
+10.7% |
| $457,961 |
| 0.0% |
| $64.10 |
27 |
| 2025-Q4 | Increased | 6,599 | +23.5% | $438,108 | 0.0% | $67.25 | 29 |
| 2025-Q3 | Increased | 5,345 | +0.2% | $184,349 | 0.0% | $33.78 | 23 |
| 2025-Q2 | Increased | 5,335 | +29.5% | $84,293 | 0.0% | $16.08 | 27 |
| 2025-Q1 | Decreased | 4,121 | -0.6% | $56,952 | 0.0% | $13.82 | 0 |
| 2024-Q4 | Decreased | 4,147 | -7.8% | $78,627 | 0.0% | $18.61 | 0 |
| 2024-Q3 | Increased | 4,496 | +21.3% | $88,436 | 0.0% | $19.67 | 26 |
| 2024-Q2 | Decreased | 3,708 | -98.9% | $95,259 | 0.0% | $25.99 | 0 |